We use cookies for behaviour analytics. Learn more
Technology · Equity Analysis
Salesforce Inc. (CRM) Stock Analysis - DCF Valuation & AI Disruption Risk
By Anton Ladnyi, CFA · ex-Goldman Sachs · ex-J.P. MorganPublished Updated
CRM — Salesforce on ~9x forward P/E (stock ~$170, down ~42% YTD, hit 52-week low $146 on June 22 during record 14-day losing streak) is pursuing aggressive AI M&A: acquired Fin (AI customer service, 76% autonomous resolution rate, 30K clients) for $3.6B on June 15; Agentforce + Data 360 total AI/Data ARR now ~$3.4B; removed from Russell Top 50; FY27 guidance $45.9-46.2B; consensus Buy $252 avg PT (~+48% upside).
Quantitative model rating — not individualized investment advice.
How Is This Rating Calculated?
A.L. Capital Advisory Equity Composite model · calculated 2026-08-08. Four calculation steps, in order — steps 1, 2 and 4 are rules-based; step 3 is a disclosed qualitative analyst overlay mapped to a fixed numerical scale:
1. Margin of safety → quantitative grade
CRM's margin of safety is +25.70% (base case $259 vs. price $192.74). Margin of safety here is defined as (fair value − price) / fair value — this is the formula the quant grade below is actually assigned from. It is not the same figure as the gauge's "Upside to Base" pill above, which uses (fair value − price) / price and will read a larger number for the same inputs. For comparison, the pure (unblended) DCF output alone implies a margin of safety of +38.31% (pure DCF base $312 vs. price $192.74) — the gap between this and the +25.70% blended figure above reflects the analyst-consensus blend.
Blended valuation margin-of-safety bands
Margin of safety
Quant grade
Score
MOS > 20.00%
Strong Buy
5.0
10.00% < MOS ≤ 20.00%
Buy
4.0
−10.00% < MOS ≤ 10.00%
Hold
3.0
−20.00% < MOS ≤ −10.00%
Reduce
2.0
MOS ≤ −20.00%
Avoid
1.0
2. Auto fundamental penalty
No fundamental red flags triggered · total: +0.0
Automatic fundamental-penalty rules
Rule
Threshold
Penalty
P/E extreme
Forward (or trailing) P/E > 80x
−1.0
P/E elevated
Forward (or trailing) P/E 50–80x
−0.5
Earnings deterioration, significant
Earnings growth < −20%
−1.0
Earnings deterioration, mild
Earnings growth −5% to −20%
−0.5
Stagnant top-line
Revenue growth < 3%
−0.5
Unsustainable dividend
Payout ratio > 120%
−0.5
Rules are cumulative (multiple can fire on the same ticker) and purely mechanical — no analyst judgment is involved in step 2.
3. Thesis conviction modifier
Analyst conviction: medium-high · modifier: +0.00. This is a qualitative analyst judgment on the written thesis, mapped to a fixed numeric modifier below — it is not algorithmically derived from a measurable indicator.
Analyst-conviction modifier scale
Conviction level
Modifier
Very High
+1.00
High
+0.60
Medium
+0.00
Low
-0.60
Very Low
-1.00
General guidance for the assigning analyst (not an algorithmic rule — conviction is assigned by editorial judgment on the written thesis, not computed): Very High/High — multiple thesis pillars confirmed by the most recent reported quarter, no unresolved red flags. Medium — mixed evidence, or a thesis not yet differentiated enough to lean either direction. Low/Very Low — one or more thesis pillars deteriorating, or a material data-quality concern. Assigned and reviewed each time the underlying thesis is updated (see the thesis "last updated" date on this page).
This is the exact formula the model runs — not a post-hoc explanation. Source: composite_grade.py, A.L. Capital Advisory Equity Composite.
CRM Price Target & Rating
CRM's quantitative grade is Strong Buy, with elevated downside risk (CVaR -28.0%), and quality metrics (net margin 19%, ROE 17%). Salesforce Inc. (CRM) trades at $192.74 with a Strong Buy composite rating: a trailing P/E of 21.7x at a 32% discount to sector median, net margins of 18.7%, a blended fair-value range of $172–$472 suggesting a +26% margin of safety, beta 1.15 (moderate risk profile).
What Is CRM's DCF Intrinsic Value and Blended Fair Value Range?
CRM's blended fair-value range is $172–$472 (base case $259), against a current price of $192.74.
CRM blended fair-value gauge — bear case $172, base case $259, bull case $472, current price $192.74.
Price & DCF data as of
How Does CRM's Margin of Safety Change as the Price Moves?
Drag to simulate CRM's price moving between the blended bear ($172) and bull ($472) fair-value anchors — left for a price fall, right for a rise — and see how the margin of safety vs A.L. Capital Advisory's $259 blended base-case fair value changes. Starting point: the page's as-of price of $192.74 on 2026-08-08.
DCF Assumptions
Two-stage earnings-based DCF on forward EPS of $15.51 (Yahoo Finance forwardEps: provider-aggregated next-fiscal-year consensus estimate, not a fixed trailing-12-month window): explicit 5-year forecast at the stage-1 growth rate below, discounted at the CAPM cost of equity, plus a Gordon Growth terminal value at the terminal growth rate, also discounted at the CAPM cost of equity. This model discounts projected EPS — an equity-level metric — directly, not free cash flow, so the cost of equity is the theoretically correct discount rate; this is not a debt-weighted WACC (no cost of debt or capital-structure weighting is applied). Source: A.L. Capital Advisory DCF engine (api.py).
DCF assumptions by scenario
Input
Bear
Base
Bull
Stage-1 (near-term) growth
6.30%
14.00%
21.00%
Terminal growth
3.00%
3.00%
3.00%
CAPM cost of equity (discount rate)
11.88%
11.00%
10.12%
Forecast horizon
5 years
5 years
5 years
CAPM cost of equity = risk-free rate (4.66%, a live 10-year Treasury yield (Yahoo Finance ^TNX) fetched at page-generation time, 2026-08-08T11:06:12+00:00 UTC) + beta (1.15) × 5.5% equity risk premium, floored at 6% and capped at 18%. Stage-1 growth is a sector-level base rate (bear/bull apply 0.45x/1.50x multipliers); terminal growth is held constant across scenarios. Bear/bull cost of equity applies a ±8% relative adjustment to the base rate, clamped to the same 6–18% band.
The DCF output above is not the final intrinsic value shown elsewhere on this page. It is blended with the Wall Street analyst consensus price target to avoid extreme single-model divergence, weighted by analyst coverage depth (53 analysts covering this stock → 25.00% DCF / 75.00% consensus). The blended figure is the intrinsic value used for margin-of-safety and the composite rating.
DCF-to-intrinsic-value blend by scenario
Scenario
Pure DCF value
Analyst target used
Blended intrinsic value (displayed)
Bear
$206.12
$160.00
$171.53
Base
$312.45
$241.72
$259.40
Bull
$463.51
$475.00
$472.13
Blended value = (25.00% × pure DCF) + (75.00% × analyst target). Bear/bull scenarios blend against the analyst low/high target rather than the mean.
Analyst-coverage-to-consensus-weight tiers
Analyst coverage
Weight
0–1 analysts
0.00% consensus / 100.00% DCF
2–4 analysts
40.00% consensus / 60.00% DCF
5–19 analysts
65.00% consensus / 35.00% DCF
20+ analysts
75.00% consensus / 25.00% DCF
The consensus weight is a fixed step function of analyst coverage depth (above), not adjusted for target age, dispersion, or outliers — the mean/low/high analyst targets are used as reported by the data provider with no filtering.
Key Takeaways
Valuation: Strong Buy grade — P/E 21.7x — blended fair-value range $172–$472 implies +26% margin of safety
Risk: CVaR -28.0% (95th percentile, 1-month) indicates moderate tail exposure; beta of 1.15 amplifies broad market moves in both directions
Strengths: Size 4.0/5, 19% net margin, 17% ROE dominate the factor profile
Catalyst: Q2 FY2027 earnings Sept 2, 2026 — must show billings re-acceleration and Agentforce ARR crossing $1.5B+ to reverse narrative; Fin acquisition regulatory close (Q4 FY2027 expected); Russell rebalancing overhang clearing; any demonstration that AI agents expand TAM rather than cannibalize seat-based revenue.
Bear catalyst: Billings growth remains below 5%; cRPO growth decelerates below 10%; large customer churn to Microsoft Dynamics; Agentforce fails to cross $2B ARR by FY2028
CRM — Quantitative SnapshotAugust 2026
RatingStrong Buy
Price$192.74
Why Strong BuyAttractive valuation relative to peers with solid fundamentals
Main riskElevated tail risk — CVaR -28.0% on a one-month horizon
Tail riskCVaR -28.0% over one month at the 95th percentile
Blended fair-value range$172–$472 blended fair-value range; margin of safety +26%
Best useCore large-cap Technology holding — not a source of diversified sector exposure
Next watchEarnings surprise deceleration trend — monitor next quarter delivery closely
How Does CRM Score on the Five-Factor Quantitative Model?
CRM's composite five-factor score is 3.5/5, led by Value (4.5/5) and weakest on Quality (3.0/5).
CRM five-factor radar — Value 4.5, Quality 3.0, Momentum 3.0, Volatility 3.0, Size 4.0 (out of 5).
Value
4.5 / 5
Quality
3.0 / 5
Momentum
3.0 / 5
Volatility
3.0 / 5
Size
4.0 / 5
CRM Five-Factor Quantitative Scores
Factor
Score
Value
4.5 / 5
Quality
3.0 / 5
Momentum
3.0 / 5
Volatility
3.0 / 5
Size
4.0 / 5
What Is CRM's AI-Era Durability and Disruption Risk?
AI Disruption Risk: Moderate
Salesforce's AI durability story has shifted from skepticism to hard numbers: Agentforce, combined with Data 360, reached roughly $2.9 billion in ARR by the end of fiscal 2026 (up over 200% year-over-year), with Agentforce itself crossing $800 million in ARR in Q4 FY26 and surpassing $1 billion by Q1 FY27, across more than 29,000 cumulative deals. The credible disruption risk is less about Agentforce failing to gain traction and more about market structure: ServiceNow has directly invaded CRM territory with its own 'Autonomous CRM' suite, while AI-native point-solution startups threaten a more existential shift -- selling finished outcomes rather than software tools, potentially bypassing the per-seat licensing model entirely. So far platform bundling appears to be winning, but Salesforce's market cap fell from roughly $320 billion in January 2025 to about $175 billion by April 2026, reflecting investor doubt about how fast Agentforce ARR converts to overall revenue growth (guided at just 10-11% for FY27). The metric to watch is whether Agentforce/Data 360 ARR growth continues compounding at triple-digit rates while overall subscription revenue growth reaccelerates, versus AI revenue simply cannibalizing legacy per-seat license spend.
Key Metrics
CRM Key Metrics — Salesforce Inc. 2026
Metric
Value
Current Price
$192.74
P/E Ratio (TTM)
21.7x
Forward P/E
12.4x
PEG Ratio
0.24x
P/S Ratio
3.7
EV/EBITDA
14.6
Beta
1.15
Net Margin
18.7%
ROE
16.9%
Debt/Equity
124.3%
Dividend Yield
0.91%
CVaR (95%, 1M)
-28.0%
Market Cap
$157.9B
1-Month CVaR Methodology
The 1M CVaR-95 figure shown in Key Metrics, the peer comparison table and this page's hero card is computed as follows:
Lookback: most recent 1 year of daily prices.
Return input: daily log returns on dividend/split-adjusted close prices.
Confidence level: 95% (worst 5% of the resulting rolling-month observations).
Quantile convention: floor-based cutoff — the worst floor(N × 0.05) rolling-month observations (minimum 1), not a rounded or interpolated percentile.
CVaR: arithmetic mean of that worst-5% tail, expressed as a percentage.
Corporate actions: reflected via adjusted-close pricing (dividends and splits are accounted for).
1M CVaR-95 by lookback window
Method
1M CVaR-95
Trailing 1-year historical
-28.0%
Trailing 3-year historical
-22.1%
Trailing 5-year historical
-21.6%
The 1-year figure is what appears elsewhere on this page. Because it is built from overlapping 21-day windows over a single year, it reflects roughly the last ~11 non-independent tail events and is sensitive to the specific market regime of that year — treat it as a trailing-window historical estimate, not a structurally stable long-run risk parameter. The 3- and 5-year figures use the same methodology over longer, more regime-diverse histories.
This is a separate calculation from the 1-Day VaR/CVaR shown in the Tail Risk Profile chart below, which uses raw (non-overlapping) daily returns rather than rolling monthly sums — see that chart's own methodology note for the daily-horizon convention.
Tail Risk Profile
Historical Simulation · Daily Log Returns
CRM — Daily Return Distribution
Salesforce Inc. · 250 trading days · CVaR illustrated on real data
Aug 2025 – Aug 2026
Daily log returns
95%
-4.24%
1-Day VaR · 95%
95th-percentile loss threshold
-5.70%
1-Day CVaR · 95%
Avg loss in tail
13
Days in tail
of 250 sessions
250
Daily returns
Aug 2025 – Aug 2026
Historical VaR uses the nearest-rank convention: the worst observation within the tail (empirical (1−confidence) fraction of trading days). Historical CVaR is the arithmetic mean of all observations at or below that VaR threshold — so VaR is always included inside the CVaR tail, not one observation outside it.
Anton Ladnyi, CFA · A.L. Capital AdvisoryUpdated 2026-08-08
Rating Rationale
CRM — Salesforce on ~9x forward P/E (stock ~$170, down ~42% YTD, hit 52-week low $146 on June 22 during record 14-day losing streak) is pursuing aggressive AI M&A: acquired Fin (AI customer service, 76% autonomous resolution rate, 30K clients) for $3.6B on June 15; Agentforce + Data 360 total AI/Data ARR now ~$3.4B; removed from Russell Top 50; FY27 guidance $45.9-46.2B; consensus Buy $252 avg PT (~+48% upside).
Investment Thesis
↑ Bull Case
Agentforce ARR $1.2B (+205% YoY); combined AI + Data 360 ARR $3.4B (+200%+); 3.8B Agentic Work Units delivered — monetisation inflecting from seats to usage
Record $50B share buyback authorization + $25B accelerated repurchase; dividend raised; aggressive capital return at ~15x forward P/E is compelling
cRPO $33.6B (+14% YoY); total RPO $67.9B (+11%); revenue guidance raised slightly to $45.8-46.2B
Usage-based Agentforce monetisation (per completed work unit) could dramatically expand revenue-per-customer if it scales
Agentforce ARR reached $1.2B (+205% YoY) in Q1 FY2027; combined Agentforce + Data Cloud ARR surpassed $3B (+200%+); 3.8B Agentic Work Units delivered — usage-based AI monetization accelerating; FY2026 full-year revenue $41.5B, FY2027 guide >$46B; FIFA World Cup 2026 Official Supporter partnership
Fin acquisition ($3.6B, June 15): adds AI agent with 76% autonomous support resolution rate, 30,000 enterprise clients, and Apex AI model to fold into Agentforce; second Agentforce-layer M&A in 13 days (Contentful acquired June 2) — signals deliberate platform assembly strategy.
Agentforce momentum: 28.6T tokens processed (+152% QoQ), 3.8B agentic work units (+111% QoQ); total AI/Data ARR ~$3.4B; InvestingPro fair value ~57% above current price; RSI firmly oversold.
Valuation now compelling: ~9x forward P/E vs. historical 20-25x; $50B buyback authorized; FY27 guidance reiterated $45.9-46.2B; 32 Buy / 7 Outperform out of 54 analysts; Russell Top 50 removal forces index selling to clear, potentially reducing technical overhang.
↓ Bear Case
Billings growth only +3.6% YoY — the forward indicator for revenue acceleration; weak billings suggests new business signings are soft
Organic growth ~10% vs 20%+ historical norm; Informatica acquisition contributes ~$428M to subscription revenue — organic growth is lower
BofA Underperform rating ($160 price target) citing underwhelming Agentforce monetisation pathways; enterprise AI ROI debate delaying deals
Down 33% YTD — stock may be 'cheap' at 15x but the multiple re-rating requires billings acceleration that hasn't materialised
Microsoft Dynamics and AI-native CRM alternatives gaining enterprise traction
Record 14-day losing streak to 52-week low $146.32 (June 22); stock down ~42% YTD and ~60% from $368 ATH (Dec 2024); removed from Russell Top 50 adds forced selling pressure.
'SaaSpocalypse' AI disruption fear intensifying: market pricing 'AI agents replace SaaS' not 'SaaS evolves'; Agentforce ARR at $1B still <3% of $46B revenue run-rate; organic subscription growth only 7.7% constant currency ex-Informatica.
Multiple analyst PT cuts: Morningstar cut $317→$255; Northland, Citi, UBS, Wells Fargo, Bernstein all moved lower; BofA Underperform $160 PT maintained; recent data breach adds reputational risk on top of structural SaaS obsolescence fears.
What Changes the Rating
↑Catalyst:Billings growth re-accelerates to 15%+ for two consecutive quarters; Agentforce ARR reaches $3B; usage-based revenue exceeds 20% of total
↓Model downgrade conditions:Billings growth remains below 5%; cRPO growth decelerates below 10%; large customer churn to Microsoft Dynamics; Agentforce fails to cross $2B ARR by FY2028
Anton’s personal note
The model points to a strong buy and the DCF math backs it — there is real margin of safety here, which is rare at this stage of the cycle. The DCF gap is striking — the model sees 35% upside, and market consensus is not pricing it. I watch for the catalyst that closes that gap: an earnings beat that resets forward estimates, a sector re-rating, or a margin inflection. Without a visible catalyst, valuation gaps can stay wide longer than logic suggests they should. If the thesis holds across the next two quarters, I would be comfortable carrying this at a meaningful weight. If not — specifically, if margins disappoint or the earnings beat streak breaks — I would reduce before the market fully reprices.
— Anton Ladnyi, CFA
Earnings History
CRM Earnings History — EPS Surprise Rate 2026
Quarter
EPS Est. (consensus)
EPS Actual (adjusted, consensus basis)
Surprise
Q2 2026
$3.13
$3.88
+24.1% ✓
Q1 2026
$3.05
$3.81
+24.9% ✓
Q4 2025
$2.86
$3.25
+13.6% ✓
Q3 2025
$2.78
$2.91
+4.7% ✓
EPS Actual is on the same adjusted/non-GAAP basis as the consensus estimate it is compared against (excludes one-time items, consistent with how Wall Street EPS estimates are typically constructed) — it will generally differ from the company's GAAP diluted EPS as reported in its official financial statements. Verify the GAAP figure against the issuer's original earnings release if that basis is what you need.
How Has CRM Performed vs. Wall Street EPS Estimates?
CRM has beaten consensus EPS estimates in 4 of the last 4 reported quarters (100%).
CRM quarterly EPS — estimate vs. actual, 4 most recent reported quarters, 100% beat rate.
Earnings Projections
CRM Forward EPS Consensus Estimates 2026
Quarter
EPS Est.
YoY EPS
Analysts
Q3 2026
$3.27
+12.4%
43
Q4 2026
$3.36
+3.5%
42
Q1 2027
~$3.62
-5.0%
51
Q2 2027
~$3.88
+0.0%
53
~ Estimated from annual consensus — not a direct analyst survey
What Are Wall Street's EPS Estimates for CRM?
Wall Street's next-quarter consensus EPS estimate for CRM is $3.27.
CRM consensus EPS estimates, next quarter $3.27, 4 quarters shown.
Revenue growth × exit multiple (editorial, not mechanically reproducible from disclosed inputs) · hover each scenario for detail · current price $192.74
▼
Bear Case
$130
-32.6%
Implied NTM P/E: 9.2x (target ÷ next-4Q consensus EPS — distinct from the exit multiple below, which is applied to a later-year EPS estimate)
5% revenue CAGR · 12x exit multiple
◆
Base Case
$210
+9.0%
Implied NTM P/E: 14.9x (target ÷ next-4Q consensus EPS — distinct from the exit multiple below, which is applied to a later-year EPS estimate)
10% revenue CAGR · 18x exit multiple
▲
Bull Case
$330
+71.2%
Implied NTM P/E: 23.3x (target ÷ next-4Q consensus EPS — distinct from the exit multiple below, which is applied to a later-year EPS estimate)
16% revenue CAGR · 25x exit multiple
How Correlated Is CRM With Its Sector Peers?
6 of 10 peer pairs correlated above 0.60, indicating partial historical diversification — some pairs move together closely enough to blunt the benefit of holding both.
CRM pairwise correlation heatmap across 5 peers — 6 of 10 pairs above 0.60.
6 of 10 peer pairs correlated above 0.60, indicating partial historical diversification — some pairs move together closely enough to blunt the benefit of holding both.
Extended Analysis — Buy, Hold or Sell? Risk Factors. Portfolio Fit.
Is CRM a buy, hold, or sell?
CRM carries a quantitative grade of Strong Buy. At a trailing P/E of 21.7, the stock trades at a 32% discount to the Technology sector median of 32.0x. Our two-stage, EPS-based DCF model produces a pure model range of $206–$464. After blending with Street consensus targets, the displayed fair-value range is $172–$472 — implying a +26% margin of safety vs. blended base fair value at the current price of $192.74. The width of the range reflects genuine uncertainty in the terminal growth rate assumption: the correct framework is a probability-weighted distribution over scenarios, not a single point estimate. See the DCF valuation framework for full methodology.
CRM has beaten consensus estimates in 100% of the last 4 reported quarters, signalling strong execution consistency. The most recent quarter delivered a 24.1% earnings surprise. Analyst estimate revisions are trending upward.
What are CRM's key risk factors?
With a beta of 1.15, CRM exhibits an above-market risk profile relative to the broad market. The 95th-percentile CVaR of -28.0% on a one-month horizon should inform position sizing directly: at a 10% portfolio weight, this standalone tail outcome corresponds to approximately 2.8% of portfolio value before accounting for correlations with other holdings — not a marginal portfolio CVaR contribution, which depends on the full covariance structure. Net margins stand at 18.7%. Return on equity of 16.9% suggests solid capital efficiency. Leverage is moderate with debt-to-equity at 124%.
The options market shows a put/call ratio of 1.22, reflecting a notably bearish skew in derivative positioning. Implied and realized volatility are roughly aligned at 52.2% and 50.5% respectively. Insider transactions show net buying of $8.3M over the disclosed transactions from 2025-09-11 to 2026-07-22, a signal often associated with management confidence. Short interest stands at 6.6% of float, a moderate level.
How does CRM fit in a diversified portfolio?
At typical HENRY portfolio weights — 10–20% of the equity allocation — CRM carries a beta of 1.15, meaning it amplifies broad market moves proportionally. The appropriate weight is not a function of conviction alone, but of the full covariance structure across all holdings. See the Ledoit-Wolf covariance framework for the methodology behind these calculations.
Among closely correlated names, CRM shows the strongest co-movement with NOW (0.80), WDAY (0.79), SAP (0.67). Investors seeking diversification should note these correlation dynamics when constructing multi-asset portfolios. With the top peer correlation at 0.80, adding CRM to a portfolio that already holds these names provides limited marginal diversification benefit — particularly during stress events when correlations converge toward 1.0.
True portfolio risk is a function of the full covariance structure across all holdings — not individual stock metrics. The Portfolio Health Check quantifies this at the portfolio level: it surfaces hidden concentration, marginal CVaR contributions, and the degree to which your overall allocation deviates from an optimal risk-adjusted mandate. The CRM analysis here is a single node in that larger structure.
What is CRM's AI-Era Durability & Disruption Risk Score?
Salesforce's AI durability story has shifted from skepticism to hard numbers: Agentforce, combined with Data 360, reached roughly $2.9 billion in ARR by the end of fiscal 2026 (up over 200% year-over-year), with Agentforce itself crossing $800 million in ARR in Q4 FY26 and surpassing $1 billion by Q1 FY27, across more than 29,000 cumulative deals. The credible disruption risk is less about Agentforce failing to gain traction and more about market structure: ServiceNow has directly invaded CRM territory with its own 'Autonomous CRM' suite, while AI-native point-solution startups threaten a more existential shift -- selling finished outcomes rather than software tools, potentially bypassing the per-seat licensing model entirely. So far platform bundling appears to be winning, but Salesforce's market cap fell from roughly $320 billion in January 2025 to about $175 billion by April 2026, reflecting investor doubt about how fast Agentforce ARR converts to overall revenue growth (guided at just 10-11% for FY27). The metric to watch is whether Agentforce/Data 360 ARR growth continues compounding at triple-digit rates while overall subscription revenue growth reaccelerates, versus AI revenue simply cannibalizing legacy per-seat license spend.
What is CRM's intrinsic value and DCF price target?
A.L. Capital Advisory's model produces a blended fair-value range (25% pure DCF, 75% analyst consensus for well-covered names) of $172 (bear case) to $472 (bull case) for Salesforce Inc. (CRM). At $192.74, the margin of safety vs. blended base case is +26% (positive = discount to fair value; negative = premium). The bear-to-bull spread reflects genuine sensitivity to the two dominant DCF inputs: the terminal growth rate and the CAPM cost of equity (this model discounts EPS, an equity-level metric, so the cost of equity rather than a debt-weighted WACC is the applicable discount rate). Terminal value typically accounts for 60-80% of total intrinsic value in most equity DCF models, which is why a range is more analytically sound than a point estimate. The central analytical question is not what the DCF outputs as a single number but which growth trajectory the current market price already discounts. All DCF analysis follows CFA Institute standards and is conducted by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: DCF Valuation Framework →
Is CRM a buy or sell in 2026?
Salesforce Inc. (CRM) carries a Strong Buy quantitative rating from A.L. Capital Advisory, set by Discounted Cash Flow margin-of-safety band with no analyst-conviction overlay applied. Five-factor model scoring (Value, Quality, Momentum, Volatility, Size) and CVaR tail risk measurement are shown separately on the page. At $192.74, the margin of safety vs. blended base fair value is +26% (blended fair-value range: $172 bear – $472 bull). That places the current price in the Fair Range zone of A.L. Capital Advisory's DCF framework, which sets the quantitative grade component that determines this rating. Composite factor score: 3.5/5. Strongest factor: Value (4.5/5). Weakest factor: Quality (3.0/5). Trailing P/E: 21.7x. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Rating Methodology (this page) →
What is the average analyst target price for CRM?
Wall Street consensus target for CRM: $241.72 (+25.4% upside from the current price of $192.74). The analyst target range spans $160.00 (most bearish) to $475.00 (most bullish). Consensus recommendation: Buy. Note that analyst price targets typically reflect a 12-month forward horizon and are derived from a blend of DCF, comparable-company, and sum-of-the-parts analysis. A.L. Capital Advisory's Strong Buy composite rating is calculated from the blended margin-of-safety grade, applicable automatic fundamental penalties, and a disclosed qualitative analyst-conviction overlay — not from five-factor scores or CVaR, which are supporting diagnostics shown elsewhere on this page. The displayed blended fair value combines the standalone DCF output with Street consensus for well-covered names (see the DCF Assumptions box for the exact blend weight), so it does not track Street consensus mechanically, but it is not fully independent of it either. When the composite rating and the Street consensus recommendation diverge, the divergence itself is informative: it can reflect differences in time horizon, valuation methodology, or the degree to which the current price already discounts the consensus case. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Data & Sources (this page) →
How does CRM score on Value, Quality, Momentum, Volatility, and Size?
CRM five-factor scores (A.L. Capital Advisory, 1–5 scale): Value 4.5/5 (strong) — measures the trailing P/E multiple versus the sector median (not the DCF or blended fair-value range, which are separate metrics on this page); Quality 3.0/5 (neutral) — captures profitability metrics including return on equity (ROE: 16.9%) and net margin (18.7%) — sustained above-peer ROE and margins are the model's proxy for economic moat and pricing power; Momentum 3.0/5 (neutral) — reflects recent price trajectory and earnings surprise consistency; Volatility 3.0/5 (neutral) — inverse measure derived from beta, where lower historical volatility earns a higher score; Size 4.0/5 (above average) — market capitalisation rank (mega-cap $1T+ scores 5/5). Composite: 3.5/5. Factor scores above 4.0 signal a tailwind in that dimension; below 2.0 signals a material headwind. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory.
What is CRM's tail risk and CVaR?
The 95th-percentile Conditional Value at Risk (CVaR) for CRM on a one-month horizon is -28.0%. CVaR represents the expected average loss in the worst 5% of monthly outcomes — a more conservative tail risk measure than standard VaR, which only marks the loss threshold. Beta of 1.15 indicates above-market systematic sensitivity with amplified drawdown exposure — beta measures historical sensitivity to market moves, not total volatility. For reference, a diversified S&P 500 ETF carries a one-month CVaR of roughly -8% to -12% in normal market conditions; individual equity CVaR is higher due to idiosyncratic risk. At the portfolio level, what matters is the marginal CVaR contribution of each holding — not its standalone figure. The A.L. Capital Advisory Portfolio Health Check quantifies each position's marginal tail-risk contribution across your entire holdings. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: CVaR & Tail-Risk Methodology →
What would trigger a rating upgrade or downgrade for CRM?
Higher-conviction trigger: Evidence supporting the upper end of the Strong Buy range, such as accelerating earnings surprise magnitude combined with improvement in the Value factor score — specifically if the current 21.7x P/E is supported by an upward revision to DCF terminal growth assumptions. Downgrade trigger: An earnings miss at current valuations (21.7x trailing P/E) where there is limited earnings cushion to absorb negative surprises; or a sustained reversal in the Quality and Momentum factor scores for two or more consecutive quarters. These triggers are reassessed each time the underlying fundamentals, price, or earnings data refresh — the current Strong Buy rating is not held on a fixed review calendar. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Rating Methodology (this page) →
Does CRM consistently beat earnings estimates?
CRM has beaten consensus EPS estimates in 4 of the 4 most recently reported quarters (100%) — indicating consistent delivery across the latest 4 reported quarters. The most recent reported quarter beat consensus by 24.1%. Sustained above-consensus delivery supports both the Momentum and Quality factor scores and provides a tailwind to the current rating. Across the 4 most recently reported quarters with valid consensus data, a beat rate above 70% signals consistent execution in this model, while a rate below 50% typically corresponds to a Momentum factor score of 3.0/5 or below. Earnings surprise magnitude and direction are incorporated into the Momentum and Quality dimensions of the five-factor scoring model. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Earnings History (this page) →
How does CRM contribute to portfolio risk and diversification?
CRM carries a beta of 1.15 (high-volatility / growth-sensitive relative to the broad equity market). A beta above 1.0 means the position amplifies market moves in both directions at a typical portfolio weight. Strongest peer co-movement: NOW (0.80), WDAY (0.79), SAP (0.67). Holding CRM alongside these names in the same portfolio increases concentration risk. True portfolio risk is a function of the full covariance structure — a single stock's beta does not reveal its marginal contribution to portfolio tail loss. The A.L. Capital Advisory Portfolio Health Check quantifies concentration risk (Herfindahl-Hirschman Index), pairwise correlations, and marginal CVaR contribution across all your holdings. If a single position such as this one makes up an outsized share of your net worth — employer stock, RSUs, or concentrated equity compensation — a Strategic Session builds the sequencing plan and the written allocation that follows from it. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: Ledoit-Wolf Covariance Framework →
What quantitative methodology does A.L. Capital Advisory use to analyse CRM?
A.L. Capital Advisory analyses Salesforce Inc. (CRM) using a four-part quantitative research framework grounded in CFA Institute standards (not all four parts feed the composite rating formula directly — see below). (1) DCF Valuation: a two-stage earnings-based DCF that projects EPS (not free cash flow) under bear and bull assumptions, discounts at the CAPM cost of equity (the applicable rate for an equity-level metric like EPS, not a debt-weighted WACC) to produce an intrinsic value range with margin-of-safety calculation. (2) Five-Factor Scoring: each equity is scored 1–5 on Value, Quality, Momentum, Volatility, and Size. (3) CVaR Tail Risk: 95th-percentile Conditional Value at Risk from historical simulation of daily returns on a one-month horizon. (4) Earnings Surprise Analysis: quarterly beat rate and magnitude, shown for context alongside the factor scores. The current Strong Buy composite rating for CRM is calculated separately from this broader framework: it consists of a Strong Buy quantitative grade, any automatic fundamental penalty, and a disclosed qualitative analyst-conviction overlay — see this page's Rating Methodology section for the exact formula. Five-factor scoring, CVaR and earnings surprise analysis below are supporting research diagnostics shown separately on this page; they are not direct numerical inputs into this specific composite-rating calculation. Analysis by Anton Ladnyi, CFA (ex-Goldman Sachs, ex-J.P. Morgan) · A.L. Capital Advisory. Full methodology: DCF Valuation Framework → · CVaR & Tail-Risk Methodology →
Stress-Test This View Live
Run CRM in Asset Lens
Live DCF valuation, Monte Carlo simulation, options flow intelligence, and full factor decomposition — updated in real time. Free, no account required.
Retrieved 2026-08-08T11:06:12+00:00 (UTC); see per-quarter analyst counts in Earnings Forecast; individual target ages/dates are not disclosed by the data provider
Most recent exchange settlement date on file with the data provider (exact settlement date not exposed by the provider's API; retrieved 2026-08-08T11:06:12+00:00 UTC)
[6] DCF valuation, five-factor model & composite rating
Calculated 2026-08-08T11:06:12+00:00 (UTC); see Rating Methodology above for the exact formula
Hand-authored thesis commentary (bull/bear case, catalysts, AI-Era Durability Score narrative) is cross-checked against the company's own investor-relations disclosures at time of writing; figures presented as A.L. Capital Advisory estimates are proprietary forecasts, not company guidance, unless explicitly attributed to the issuer.
Market-session status above is derived from the page's UTC generation time using standard NYSE hours (9:30am–4:00pm ET regular session); it does not account for US market holidays and may be inaccurate on those dates.
Download this page's underlying data: JSON → · CSV →
Legal Disclaimer & Important Notices
This analysis is produced using a systematic quantitative framework applied to market data and does not constitute investment advice. Prose commentary is AI-assisted and generated from structured quantitative inputs. All data and metrics are as of 2026-08-08 and are point-in-time estimates subject to revision without notice. CVaR figures are based on historical simulation and do not guarantee future outcomes. DCF ranges and upgrade/downgrade triggers are forward-looking statements based on current assumptions and may not materialise. Past performance does not guarantee future results. This analysis does not account for individual circumstances, tax position, or investment objectives — consult a qualified financial advisor before making investment decisions. This content is intended for informational purposes only and does not constitute regulated investment advice under MiFID II or FCA guidelines. This content is not intended for US persons or residents of jurisdictions where its distribution would be contrary to local law or regulation. This service is not directed at residents of Finland, Sweden, Norway, Denmark, Iceland, or Poland. The author may hold long or short positions in securities mentioned in this analysis. Nothing on this page represents a solicitation to buy or sell any security. A.L. Capital Advisory is an independent private advisory practice and is not affiliated with Salesforce Inc.
CFA Portfolio Advisory — CRM
Discuss this analysis, position sizing, or your full portfolio mandate with Anton Ladnyi, CFA.